WO2004007513A1 - Method for producing 2-deoxy-l-ribose - Google Patents

Method for producing 2-deoxy-l-ribose Download PDF

Info

Publication number
WO2004007513A1
WO2004007513A1 PCT/KR2003/001398 KR0301398W WO2004007513A1 WO 2004007513 A1 WO2004007513 A1 WO 2004007513A1 KR 0301398 W KR0301398 W KR 0301398W WO 2004007513 A1 WO2004007513 A1 WO 2004007513A1
Authority
WO
WIPO (PCT)
Prior art keywords
deoxy
ribose
alkyl
acid
alcohol
Prior art date
Application number
PCT/KR2003/001398
Other languages
French (fr)
Inventor
Jae-Sung Kang
Mi-Hong Yun
Sang-Dae Lee
Byoung-Chan Jeon
Jeong-Ah Shin
Original Assignee
Samchully Pharm. Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samchully Pharm. Co., Ltd. filed Critical Samchully Pharm. Co., Ltd.
Priority to CA002492558A priority Critical patent/CA2492558A1/en
Priority to AU2003281047A priority patent/AU2003281047A1/en
Priority to US10/521,022 priority patent/US7304154B2/en
Priority to JP2004521271A priority patent/JP2005538080A/en
Priority to EP03741579A priority patent/EP1556396A4/en
Publication of WO2004007513A1 publication Critical patent/WO2004007513A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/08Deoxysugars; Unsaturated sugars; Osones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02Monosaccharides

Definitions

  • the present invention relates to a synthetic method for the compound having compound (1) below, more specifically, to a mass-produceable and cost-effective synthetic method of compound (1) from 2-Deoxy-D-ribose with easy reaction, separation, and purification.
  • compound (1)
  • L-nucleosides are attracting attention as antiviral agents.
  • Some L-nucleosides such as L-thymidine, L-2'-thiacytidine (3TC) and L- 2',3'-dideoxycytidine (L-ddC) are much less toxic and have better antiviral activity than their D-isomers.
  • L-nucleosides have good effect in antisense oligonucleotide therapy.
  • the objective of the present invention is to provide a synthetic process of 2-deoxy-L-robse, which allows the cost-effective and large-scale synthesis thanks to the short process, the easy reaction and purification.
  • the present invention provides the synthetic process of compound (1) comprising 4 steps; protection, activation and inversion of 3- and 4-OH groups of 2-deoxy-D-ribose, and deprotection.
  • the present invention provides the synthetic process of compound (1) comprising the steps of; (A) protection step in which aldehyde group of 2-deoxy-D-ribose is protected in the form of acetal. 2-deoxy-l-O-alkyl-D-ribopyranoside is prepared by the reaction of 2-deoxy-D-ribose with alcohol in the presence of acid; (B) activation step in which 3 -and 4-OH groups of 2-deoxy-D-ribose are activated.
  • 2-deoxy-l-O-alkyl- 3 ,4-di-(alkanesulfonyl)-D-ribose or 2-deoxy- 1 -O-alkyl-3 ,4-di-(arylsulfonyl)-D-ribose is prepared by reaction of the above 2-deoxy-l-O-alkyl-D-ribose with organic sulfonylhalide for activation of 3- and 4-OH; (C) inversion step in which stereochemistry of 3- and 4-OH groups is changed.
  • protecting group is introduced in the form of acetal by the reaction of compound (2), 2-deoxy-D-ribose with alcohol in the presence of acid.
  • RI represents a lower alkyl having 1-5 of carbon number, a benzyl or a substituted benzyl.
  • the acid used in this step contains inorganic acid such as hydrochloric acid and sulfuric acid or organic acid such as methanesulfonic acid and p- toluenesulfonic acid and the concentration of acid is preferably 1 ⁇ 10%.
  • a lower alcohol such as methyl alcohol, ethyl alcohol, propyl alcohol and butyl alcohol, benzyl alcohol or substituted benzyl alcohol may be used.
  • compound (4), 2-deoxy-l-O-alkyl-3,4-di-(alkanesulfonyl)-D-ribose or 2-deoxy-l-O-alkyl-3,4-di-(arylsulfonyl)-D-ribose is obtained by converting 3- and 4-
  • An organic sulfonyl halide used in this step may include a lower alkanesulfonyl halide such as methanesulfonyl chloride and trifluoromethylsulfonyl chloride and arylsulfonyl halide such as bezenesulfonyl chloride and p-toluenesulfonylchloride.
  • a lower alkanesulfonyl halide such as methanesulfonyl chloride and trifluoromethylsulfonyl chloride
  • arylsulfonyl halide such as bezenesulfonyl chloride and p-toluenesulfonylchloride.
  • RI represents a lower alkyl having 1-8 of carbon number, a substituted or unsubstituted benzyl and R2 represents a lower alkylsulfonyl having 1-8 of carbon number, a substituted or unsubstituted aryl sulfonyl group.
  • a metal salt of organic acid used in this step may include a metal salt of lower alkyl organic acid such as sodium acetate, potassium acetate or a metal salt of aryl organic acid such as sodium benzoate or potassium benzoate.
  • a solvent used in this step may include water and organic solvent such as dimethylforrnamide (DMF), dimethylacetamide (DMAC), and alohols, but DMF or the mixture of water and organic solvent is preferable in view of solubility of the reactants.
  • DMF dimethylforrnamide
  • DMAC dimethylacetamide
  • alohols but DMF or the mixture of water and organic solvent is preferable in view of solubility of the reactants.
  • RI represents a lower alkyl having 1-8 of carbon number, a substituted or unsubstituted benzyl and R2 represents a lower alkylsulfonyl having 1-8 of carbon number, a substituted or unsubstituted aryl sulfonyl group.
  • Compound (1) can be used as a raw material for the further reaction without purification or can be purified by the formation of anilide derivative well known as a purification method of 2-deoxy-D-ribose to obtain as solid
  • R3 lower alkyl having 1-8 of carbon number or substituted or unsubstituted benzyl ]
  • Embodiment 2 Activation of 3- and 4-OH groups: Preparation of 2-Deoxy-l-O-butyl-3,4-di-(p- toluenesulfonyl)-D-ribose
  • Embodiment 3 Conversion to L-form sugar from D-form sugar: Preparation of 2-deoxy-l-O- butyl-3-benzoyl-L-ribose and 2-deoxy-l-O-butyl-4-benzoyl-L-ribose
  • Embodiment 2 To the compound obtained in Embodiment 2 (20g) were added n-butanol (7 mL), water (4.4mL), N,N-dimethylformamide (27.6 mL) and potassium benzoate (21.2g) and the mixture was heated to 115°C and reacted for 8 hours. After the concentration of the reaction mixture, water and ethyl acetate were added to separate organic and water layers. After the organic layer was concentrated, the residue was mixed with water and evaporated again to concentrate N,N-dimethylformamide efficiently. The residue was used for the next reaction.
  • Embodiment 3 To the residue obtained in Embodiment 3 were added water (10 mL) and 40% sodium hydroxide solution (10 mL) and the mixture was stirred for 3 hours at room temperature. 6N hydrochloric acid (50mL) was added to the reaction mixture and the resulting mixture was stirred for 4 hours at 25 ⁇ 30 °C to give 2-deoxy-L-ribose.
  • 6N hydrochloric acid 50mL was added to the reaction mixture and the resulting mixture was stirred for 4 hours at 25 ⁇ 30 °C to give 2-deoxy-L-ribose.
  • anilide derivative which was already known for its enatiomer 2-deoxy-D-ribose, pure 2-deoxy-L-ribose was obtained as solid (3.4g).
  • the present invention is related to the synthetic method for 2-deoxy-L-ribose in which reaction and purification is easy at easily attainable range of temperature and pressure, and of which reagents are more cheap and less toxic. Additionally, this invention provides more economic method than the previously known process in terms of the costs for equipments, law-materials, and processing by using the low-cost and non-toxic reagents starting from 2-deoxy-D-ribose which is naturally abundant as well as can be synthesized from D-glucose easily.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention relates to a economic synthetic method of 2-deoxy-L-ribose from 2-deoxy-D-ribose with easy reaction, separation and purification. The present invention consists of four(4) steps including protection, activation 3-and 4-OH groups, inversion and deprotection step. In respect to the cost for equipment, reagent and operation, by the present invention, 2-deoxy-L-ribose can be produced more economically because the invention uses 2-deoxy-L-ribose which is abundant in nature and easily synthesized from D-glucose, and adopt simple and yielding process.

Description

METHOD FOR PRODUCING 2-DEOXY-L-RIBOSE
TECHNICAL FIELD
The present invention relates to a synthetic method for the compound having compound (1) below, more specifically, to a mass-produceable and cost-effective synthetic method of compound (1) from 2-Deoxy-D-ribose with easy reaction, separation, and purification.
Figure imgf000002_0001
compound (1)
BACKGROUND ART
Recently, natural or modified L-nucleoside are attracting attention as antiviral agents. Some L-nucleosides such as L-thymidine, L-2'-thiacytidine (3TC) and L- 2',3'-dideoxycytidine (L-ddC) are much less toxic and have better antiviral activity than their D-isomers. In addition, L-nucleosides have good effect in antisense oligonucleotide therapy.
For the above reasons, many attempts have been made to synthesize L-nucleosides effectively which cannot be obtained as natural products. The efforts has been being focused to economic and mass-produceable preparation method for the derivatives of L-sugar, particularly, 2-deoxy-D-ribose and L-ribose which can be used as key intermediates of L-nucleosides.
Some synthetic methods for 2-deoxy-L-ribose are known from D-ribose, L- arabinose or L-ascorbic acid. (WO 9839347, CS 274394B1, Nucleosides Nucleotidees 1999, 18 (11 & 12), 2357-2365, Tetrahedron: Asymmetry 2000, 11, 1869-176, Org. Lett 1999, 1 (10), 1517-1519)
In these methods, however, expensive or highly toxic reagents are used; difficult separation and purification is required; the overall yield is low; all which are obstacles to the application in the large-scale synthesis.
DISCLOSURE OF INVENTION
Accordingly, the objective of the present invention is to provide a synthetic process of 2-deoxy-L-robse, which allows the cost-effective and large-scale synthesis thanks to the short process, the easy reaction and purification. BEST MODE FOR CARRYING OUT THE INVENTION
To achieve the above objective, the present invention provides the synthetic process of compound (1) comprising 4 steps; protection, activation and inversion of 3- and 4-OH groups of 2-deoxy-D-ribose, and deprotection. The present invention provides the synthetic process of compound (1) comprising the steps of; (A) protection step in which aldehyde group of 2-deoxy-D-ribose is protected in the form of acetal. 2-deoxy-l-O-alkyl-D-ribopyranoside is prepared by the reaction of 2-deoxy-D-ribose with alcohol in the presence of acid; (B) activation step in which 3 -and 4-OH groups of 2-deoxy-D-ribose are activated. 2-deoxy-l-O-alkyl- 3 ,4-di-(alkanesulfonyl)-D-ribose or 2-deoxy- 1 -O-alkyl-3 ,4-di-(arylsulfonyl)-D-ribose is prepared by reaction of the above 2-deoxy-l-O-alkyl-D-ribose with organic sulfonylhalide for activation of 3- and 4-OH; (C) inversion step in which stereochemistry of 3- and 4-OH groups is changed. Reaction of the above 2-deoxy-l- O-alkyl-3,4-di-(alkanesulfonyl)-D-ribose or 2-deoxy-l-O-alkyl-3,4-di-(arylsulfonyl)- D-ribose with a metal salt of organic acid leads to 2-deoxy-L-ribose derivatives of which stereochemistry of 3- and 4-OH is different from the corresponding 2-deoxy-D- ribose derivatives; (D) deprotection step in which 2-deoxy-L-ribose is prepared by consecutive reactions of the step (C) products with acid and base.
Each step will be explained in the following.
(1) Protection
In this step, protecting group is introduced in the form of acetal by the reaction of compound (2), 2-deoxy-D-ribose with alcohol in the presence of acid.
Figure imgf000005_0001
compound (2) compound (3)
Here, RI represents a lower alkyl having 1-5 of carbon number, a benzyl or a substituted benzyl. The acid used in this step contains inorganic acid such as hydrochloric acid and sulfuric acid or organic acid such as methanesulfonic acid and p- toluenesulfonic acid and the concentration of acid is preferably 1 ~ 10%. A lower alcohol such as methyl alcohol, ethyl alcohol, propyl alcohol and butyl alcohol, benzyl alcohol or substituted benzyl alcohol may be used.
(2) Activation of 3- and 4-OH groups: Preparation of 2-Deoxy-l-O-alkyl-3,4-di- (alkanesulfonyl)-D-ribose or 2-deoxy- 1 -O-alkyl-3 ,4-di-(arylsulfonyl)-D-ribose
In this step, compound (4), 2-deoxy-l-O-alkyl-3,4-di-(alkanesulfonyl)-D-ribose or 2-deoxy-l-O-alkyl-3,4-di-(arylsulfonyl)-D-ribose is obtained by converting 3- and 4-
OH groups of compound (3) into 3- and 4-sulfonyl groups by the action of organic sulfonyl halide and an organic base. The purpose of this reaction is the activation of
3- and 4-OH groups for further reaction.
An organic sulfonyl halide used in this step may include a lower alkanesulfonyl halide such as methanesulfonyl chloride and trifluoromethylsulfonyl chloride and arylsulfonyl halide such as bezenesulfonyl chloride and p-toluenesulfonylchloride. Detailed reaction condition is accordance with basic methods of organic synthesis. < ,oυ- V OUHH J D~>-- 0R
R'0- oO DWr RR1100"<^ OF
compound (3) compound (4)
Here, RI represents a lower alkyl having 1-8 of carbon number, a substituted or unsubstituted benzyl and R2 represents a lower alkylsulfonyl having 1-8 of carbon number, a substituted or unsubstituted aryl sulfonyl group.
(3) Inversion (conversion to L-sugar from D-sugar): Preparation of the mixture of 2- deoxy-l-O-alkyl-3-acyl-L-ribose and 2-deoxy-l-O-alkyl-4-acyl-L-ribose
Compound (5), the mixture of 2-deoxy-l-O-alkyl-3-acyl-L-ribose and 2-deoxy- l-O-alkyl-4-benzoyl-L-robose in which the stereochemistry of 3- and 4- carbon is changed is prepared through the reaction of compound (4) with a metal salt of organic acid.
A metal salt of organic acid used in this step may include a metal salt of lower alkyl organic acid such as sodium acetate, potassium acetate or a metal salt of aryl organic acid such as sodium benzoate or potassium benzoate. A solvent used in this step may include water and organic solvent such as dimethylforrnamide (DMF), dimethylacetamide (DMAC), and alohols, but DMF or the mixture of water and organic solvent is preferable in view of solubility of the reactants.
Figure imgf000007_0001
compound (4) compound (5)
Here, RI represents a lower alkyl having 1-8 of carbon number, a substituted or unsubstituted benzyl and R2 represents a lower alkylsulfonyl having 1-8 of carbon number, a substituted or unsubstituted aryl sulfonyl group.
(4) Deprotection
Compound (1), 2-deoxy-L-ribose is obtained by the stepwise reactions of compound (5) with acid and base. Acid and base used in deprotection conventionally may also be used in this step. The order of the stepwise reactions may be changed according to its convenience.
Figure imgf000007_0002
compound (5) compound (1)
Compound (1) can be used as a raw material for the further reaction without purification or can be purified by the formation of anilide derivative well known as a purification method of 2-deoxy-D-ribose to obtain as solid
The above preparation method is depicted in the following scheme:
Figure imgf000008_0001
(2) (3) (4)
Figure imgf000008_0002
(5) (1)
[ RI: lower alkyl having 1-8 of carbon number or substituted or unsubstituted benzyl R2: lower alkylsulfonyl having 1-8 of carbon number or substituted or unsubstituted arylsulfonyl
R3: lower alkyl having 1-8 of carbon number or substituted or unsubstituted benzyl ]
The syntheses described above provide simple preparation method of compound
(1) utilizing chief and commercially available reagents without toxic reagent such as heavy metal and easily attainable temperature and pressure range.
In addition, separation and purification is easy without special equipment because the key intermediate and final product can be purified by recrystallization.
The raw material, 2-deoxy-D-ribose is not only abundant in natural products, but also obtained by chemical synthesis. All the above reason make the procedure mass- producible effectively. To assist in understanding the present invention more clearly, the following embodiments are appended. The embodiments should not, of course, be construed to limit or alter the scope of the present invention. Further, the variations or modifications of the present invention which do not depart from the spirit of the present invention can easily be made by one of ordinary skill in the art and are considered to fall within the scope of the present invention.
PREFERRED EMBODIMENTS
Embodiment 1
Protection: Preparation of 2-deoxy-l-O-butyI-D-ribose
To a cooled butyl alcohol containing 3% HC1 (56.4 mL) was added 2-deoxy-D- robse (lOg) and stirred under -2°C for 16 hours. The reaction mixture was neutralized with triethylamine keeping the temperature under 10 °C and stirred at 20 ~ 25°C. The mixture was filtered and washed with acetone (20 mL). The combined filterate and washing solution was concentrated and used for further reaction without purification.
Embodiment 2 Activation of 3- and 4-OH groups: Preparation of 2-Deoxy-l-O-butyl-3,4-di-(p- toluenesulfonyl)-D-ribose
To the solid of 2-deoxy-l-O-butyl-D-ribose obtained in Embodiment 1 were added pyridine (36 mL), p-toluenesulfonyl chloride (42.6g) stepwise under 30°C and the mixture was stirred at 27 ~ 30 °C for 20 hours. The reaction mixture was heated to 75 ±2 °C and stirred for 2 hours. After the completion of reaction, the mixture was cooled to 15 ~ 20 °C and purified water (30mL) was added and the resulting mixture was extracted twice with ethyl acetate (30mL). The extract was concentrated and ethyl alcohol and isopropyl alcohol were added. The solution was cooled, filtered, and dried, to obtain the solid of 2-deoxy-l-O-butyl-3,4-di-(p-toluenesulfonyl)-D-ribose (23g).
Embodiment 3 Conversion to L-form sugar from D-form sugar: Preparation of 2-deoxy-l-O- butyl-3-benzoyl-L-ribose and 2-deoxy-l-O-butyl-4-benzoyl-L-ribose
To the compound obtained in Embodiment 2 (20g) were added n-butanol (7 mL), water (4.4mL), N,N-dimethylformamide (27.6 mL) and potassium benzoate (21.2g) and the mixture was heated to 115°C and reacted for 8 hours. After the concentration of the reaction mixture, water and ethyl acetate were added to separate organic and water layers. After the organic layer was concentrated, the residue was mixed with water and evaporated again to concentrate N,N-dimethylformamide efficiently. The residue was used for the next reaction.
Embodiment 4
Deprotection: Preparation of 2-deoxy-L-ribose
To the residue obtained in Embodiment 3 were added water (10 mL) and 40% sodium hydroxide solution (10 mL) and the mixture was stirred for 3 hours at room temperature. 6N hydrochloric acid (50mL) was added to the reaction mixture and the resulting mixture was stirred for 4 hours at 25 ~ 30 °C to give 2-deoxy-L-ribose. Through the formation of anilide derivative which was already known for its enatiomer 2-deoxy-D-ribose, pure 2-deoxy-L-ribose was obtained as solid (3.4g).
INDUSTRIAL APPLICABILITY
The present invention is related to the synthetic method for 2-deoxy-L-ribose in which reaction and purification is easy at easily attainable range of temperature and pressure, and of which reagents are more cheap and less toxic. Additionally, this invention provides more economic method than the previously known process in terms of the costs for equipments, law-materials, and processing by using the low-cost and non-toxic reagents starting from 2-deoxy-D-ribose which is naturally abundant as well as can be synthesized from D-glucose easily.

Claims

What is claimed is:
1. A method for producing 2-deoxy-L-ribose comprising the steps of
(A) protection step for preparation of 2-deoxy-l-O-alkyl-D-ribopyranoside, of which the aldehyde group in 2-deoxy-D-ribose is protected in the form of acetal, by reacting 2-deoxy-D-ribose with an alcohol in the presence of an acid;
(B) activation step for preparation of 2-deoxy-l-O-alkyl-3,4-di-(alkanesulfonyl)- D-ribose or 2-deoxy-l-O-alkyl-3,4-di-(arylsulfonyι)-D-ribose, of which the 3 -and 4- OH groups in 2-deoxy-D-ribose are activated, by reacting the above 2-deoxy-l-O- alkyl-D-ribose and an organic sulfonyl halide in the presence of a base;.
(C) inversion step for preparation of a mixture of 2-deoxy-l-O-alkyl-3-acyl-L- ribose and 2-deoxy-l-O-alkyl-4-acyl-L-ribose, in which the stereochemistry of 3 -OH and 4-OH groups are inverted, by reacting the above 2-deoxy-l-O-alkyl-3,4-di- (alkanesulfonyl)-D-ribose or 2-deoxy-l-O-alkyl-3,4-di-(arylsulfonyl)-D-ribose with a metal salt of organic acid; and
(D) deprotection step for preparation for 2-deoxy-L-ribose by reactions of the above mixture of 2-deoxy-l-O-alkyl-3-acyl-L-ribose and 2-deoxy-l-O-alkyl-4-acyl-L- ribose with an acid and then with a base, or with a base and then with an acid.
2. The method for producing 2-deoxy-L-ribose according to Claim 1, wherein the alcohol used in said protection step is a lower alcohol having 1-4 of carbon number, benzyl alcohol or substituted benzyl alcohol.
3. The method for producing 2-deoxy-L-ribose according to Claim 1, wherein the organic sulfonyl halide used in said activation step is a lower alkanesulfonyl halide such as methane sulfonyl chloride or trifluoromethyl chloride, or arylsulfonyl halide such as benzenesulfonyl chloride or p-toluenesulfonyl chloride.
4. The method for producing 2-deoxy-L-ribose according to Claim 1, wherein the metal salt of organic acid used in said conversion step is a metal salt of lower alkyl organic acid having 1-8 of carbon number or a metal salt of aryl organic acid.
PCT/KR2003/001398 2002-07-15 2003-07-15 Method for producing 2-deoxy-l-ribose WO2004007513A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002492558A CA2492558A1 (en) 2002-07-15 2003-07-15 Method for producing 2-deoxy-l-ribose
AU2003281047A AU2003281047A1 (en) 2002-07-15 2003-07-15 Method for producing 2-deoxy-l-ribose
US10/521,022 US7304154B2 (en) 2002-07-15 2003-07-15 Method for producing 2-deoxy-L-ribose
JP2004521271A JP2005538080A (en) 2002-07-15 2003-07-15 Method for synthesizing 2-deoxy-L-ribose
EP03741579A EP1556396A4 (en) 2002-07-15 2003-07-15 Method for producing 2-deoxy-l-ribose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0041378 2002-07-15
KR10-2002-0041378A KR100446560B1 (en) 2002-07-15 2002-07-15 Method for Producing 2-Deoxy-L-ribose

Publications (1)

Publication Number Publication Date
WO2004007513A1 true WO2004007513A1 (en) 2004-01-22

Family

ID=30113183

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/001398 WO2004007513A1 (en) 2002-07-15 2003-07-15 Method for producing 2-deoxy-l-ribose

Country Status (8)

Country Link
US (1) US7304154B2 (en)
EP (1) EP1556396A4 (en)
JP (1) JP2005538080A (en)
KR (1) KR100446560B1 (en)
CN (1) CN1668626A (en)
AU (1) AU2003281047A1 (en)
CA (1) CA2492558A1 (en)
WO (1) WO2004007513A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100849979B1 (en) 2006-12-06 2008-08-01 주식회사 삼천리제약 The preparation method of 2-deoxy-L-ribose
CN102153600B (en) * 2010-02-12 2016-09-14 何遂庆 The preparation method of 2-deoxidation-L-ribose
CN107778334A (en) * 2016-08-26 2018-03-09 康普药业股份有限公司 A kind of preparation method of Sebivo key intermediate

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675390A (en) * 1984-12-03 1987-06-23 Eli Lilly And Company 2-deoxypentose derivatives
US5220003A (en) * 1991-03-29 1993-06-15 The Regents Of The University Of California Process for the synthesis of 2',3'-dideoxynucleosides
US5659021A (en) * 1987-03-13 1997-08-19 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Chiral glycerol derivatives
WO1998039347A2 (en) * 1997-03-05 1998-09-11 The Regents Of The University Of California Synthesis of l-ribose and 2-deoxy l-ribose
KR20000008131A (en) * 1998-07-10 2000-02-07 정낙신 Thionucloside substitute and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140498A (en) * 1998-11-17 2000-10-31 Xyrofin Oy Process for the continuous production of high purity L-ribose
DE10020275A1 (en) * 2000-04-25 2001-10-31 Manfred Schneider New 2-deoxy-L-ribose and 2-deoxy-D-ribose precursors useful as intermediates for therapeutic nucleic acids and oligonucleotides
KR100440461B1 (en) * 2000-08-19 2004-07-15 (주) 한켐 Process for the preparation of L-ribose using 1,4-lactone
KR100449310B1 (en) * 2001-11-08 2004-09-18 주식회사 삼천리제약 preparation method of 2-deoxy-L-ribose
KR100433179B1 (en) * 2001-11-10 2004-05-27 주식회사 삼천리제약 Method for Producing 2-Deoxy-L-ribose

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675390A (en) * 1984-12-03 1987-06-23 Eli Lilly And Company 2-deoxypentose derivatives
US5659021A (en) * 1987-03-13 1997-08-19 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Chiral glycerol derivatives
US5220003A (en) * 1991-03-29 1993-06-15 The Regents Of The University Of California Process for the synthesis of 2',3'-dideoxynucleosides
WO1998039347A2 (en) * 1997-03-05 1998-09-11 The Regents Of The University Of California Synthesis of l-ribose and 2-deoxy l-ribose
KR20000008131A (en) * 1998-07-10 2000-02-07 정낙신 Thionucloside substitute and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1556396A4 *

Also Published As

Publication number Publication date
CA2492558A1 (en) 2004-01-22
CN1668626A (en) 2005-09-14
US7304154B2 (en) 2007-12-04
KR100446560B1 (en) 2004-09-04
EP1556396A1 (en) 2005-07-27
KR20040006826A (en) 2004-01-24
JP2005538080A (en) 2005-12-15
US20050176950A1 (en) 2005-08-11
AU2003281047A1 (en) 2004-02-02
EP1556396A4 (en) 2007-10-24

Similar Documents

Publication Publication Date Title
AU621615B2 (en) Process for the preparation of dideoxycytidine
KR20110101207A (en) Process for the synthesis of l-fucosyl dl- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof
EA018924B1 (en) Method of producing 2&#39;-deoxy-5-azacytidine (decitabine)
NO148109B (en) PROCEDURE FOR THE PREPARATION OF 5`DEOXY-5-FLUORIDINE
WO2008069440A1 (en) The preparation method of 2-de0xy-l-rib0se
FI105402B (en) Process for the Large-Scale Preparation of 2 &#39;, 3&#39;-Didehydro-2&#39;, 3&#39;-Dideoxynucleosides
US7304154B2 (en) Method for producing 2-deoxy-L-ribose
US5218098A (en) 5-(α-D-glucopyranosyloxymethyl)-furan-2-carboxaldehyde
US20150065700A1 (en) Method for preparing 3-o-benzyl-1,2-o-isopropylidene-a-l-furan idose
Ying et al. Synthesis of N-(fluoren-9-ylmethoxycarbonyl) glycopyranosylamine uronic acids
CN103476782A (en) N-substituted mannosamine derivatives, process for their preparation and their use
Jackowski et al. Formation of septanoses from hexopyranosides via 5, 6-exo-glycals
EP0350292B1 (en) Process for preparing 2&#39;-deoxy-beta-adenosine
US6566510B1 (en) Morphine-6-glucuronide synthesis
US7361745B2 (en) Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives
Mitra et al. Linear synthesis of the hexasaccharide related to the repeating unit of the O-antigen from Shigella flexneri serotype 1d (I: 7, 8)
EP0984976B1 (en) Process for the preparation of a deoxyuridine derivative
KR100433179B1 (en) Method for Producing 2-Deoxy-L-ribose
JP3163359B2 (en) Sulfated oligosaccharide compounds
CS91591A2 (en) Derivatives of 2-deoxy-d-threo-pentofuranoside, method of their preparation, intermediates for their preparation and their application
CN101497582A (en) N-substituted-1-deoxynojirimycin compound and preparation thereof
CN111171094B (en) Vanillin intermediate and preparation method and application thereof
CN106699701A (en) Preparation method of 1-O-methyl-2,3-dideoxy-L-arabinofuranose
CN101085791B (en) Method for preparing 2-deoxy-N-phenyl pentosamine
CN105713054A (en) Process For The Glycosidation Of Colchicine And Thiocolchicine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003741579

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10521022

Country of ref document: US

Ref document number: 20038166062

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2004521271

Country of ref document: JP

Ref document number: 2492558

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 186/KOLNP/2005

Country of ref document: IN

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2003741579

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003741579

Country of ref document: EP